| 1985 |
FDA clears the first nucleic acid test. |
| 1987 |
Hologic introduces the first dual-energy X-ray absorptiometry system for evaluating osteoporosis. |
| 1988 |
FDA clears the first molecular diagnostic test kit for a sexually transmitted infection. |
| 1995 |
FDA approves the Rapid fFN® test. |
| 1996 |
FDA approves the ThinPrep® Pap test, liquid-based cytology for cervical cancer screening. |
| 2001 |
FDA approves the NovaSure® endometrial ablation treatment for abnormal uterine bleeding (AUB). |
| 2002 |
FDA approves the Selenia® mammography system–the beginning of a new era in breast cancer screening. |
| 2002 |
FDA approves the first nucleic acid test for screening donated blood prior to transfusion. |
| 2003 |
Release of the Tigris® DTS® system for automated screening of sexually transmitted infections (STIs). |
| 2008 |
FDA approves the Procleix® Ultrio®* triplex blood screening assay for HIV-1, hepatitis B and C. |
| 2011 |
FDA approves the breakthrough Selenia Dimensions® |
| 2011 |
FDA approves the breakthrough Selenia Dimensions® digital tomosynthesis system with the Hologic 3D Mammography™ exam. |
| 2012 |
FDA clears the Panther® system, an automated, integrated molecular platform, for use with the Aptima Combo 2® assay. |
| 2014 |
FDA clears the use of the bone densitometer for assessing three critical health problems, including osteoporosis. |
| 2015 |
CE marked virology portfolio, including Aptima® HIV, HCV and HBV assays, along with the Aptima® M. genitalium assay. |
| 2016 |
FDA clears the new Affim® prone biopsy system. |
| 2017 |
FDA approves Aptima® HIV-1 Quant assay, Aptima® HCV Quant DX assay, and the Aptima® HSV 1 & 2 assay. The Panther Fusion® respiratory assays were approved on the Panther Fusion system. |
| 2017 |
The Brevera® breast biopsy system with CorLumina® imaging technology combines tissue acquisition, real-time imaging, verification and advanced tissue handling. |
| 2018 |
FDA clears Clarity HD high-resolution 3D™ imaging and the SmartCurve™ breast stabilization system, providing superior image quality and a clinically proven solution for a more comfortable mammogram. |
| 2019 |
The FDA grants clearance to the new Aptima® BV and Aptima® CV/TV assays, which provide an accurate and objective method for diagnosing vaginitis. |
| 2020 |
FDA grants Emergency Use Authorization (EUA) for the Panther Fusion® SARS-CoV-2 and Aptima® SARS-CoV-2 assays, molecular diagnostic tests detecting the novel coronavirus. |
